Cyclooxygenase 1 Inhibitors Market Insights Report

Dublin, June 24, 2026 (GLOBE NEWSWIRE) — The “Cyclooxygenase 1 Inhibitors – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering. The global market for Cyclooxygenase 1 Inhibitors was estimated at US$63.4 Billion in 2025 and is projected to reach US$98.8 Billion by 2032, growing at a CAGR of 6.5% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. What is Driving the Growth of the COX-1 Inhibitor Market? The growth in the COX-1 inhibitor market is driven by the rising prevalence of inflammatory disorders,…